Dr. Ina Sarel is a biotechnology executive with over 20 years of experience in product development from discovery and Proof of Concept through pre-clinical and clinical stages. Ina has broad expertise in stem/progenitor cell therapy, CMC, and regulatory requirements and previously developed a stem cell research product commercialized by Lonza.
Some of Ina’s recent positions prior to joining Nurexone, include VP Product Development at Cellect Biotechnology, VP R&D at Hemostemix, and Project Manager at Proneuron Biotechnologies.
Ina holds a Ph.D. in Neuroendocrinology from Boston University, USA.